SARM1 Inhibition as a Potential Therapeutic Strategy in ALS

Time: 12:00 pm
day: Day Two


  • SARM1 is the central driver of axonal degeneration
  • Genomics analysis suggest SARM1 as an ALS candidate risk gene
  • Downstream effects of SARM1 inhibition might potentially translate to robust biomarker, electrophysiology and clinical efficacy signals in ALS trial